274 related articles for article (PubMed ID: 11506817)
1. Signal transduction events elicited by cancer prevention compounds.
Kong AN; Yu R; Hebbar V; Chen C; Owuor E; Hu R; Ee R; Mandlekar S
Mutat Res; 2001 Sep; 480-481():231-41. PubMed ID: 11506817
[TBL] [Abstract][Full Text] [Related]
2. Antioxidants and oxidants regulated signal transduction pathways.
Owuor ED; Kong AN
Biochem Pharmacol; 2002 Sep; 64(5-6):765-70. PubMed ID: 12213568
[TBL] [Abstract][Full Text] [Related]
3. Induction of xenobiotic enzymes by the MAP kinase pathway and the antioxidant or electrophile response element (ARE/EpRE).
Kong AN; Owuor E; Yu R; Hebbar V; Chen C; Hu R; Mandlekar S
Drug Metab Rev; 2001; 33(3-4):255-71. PubMed ID: 11768769
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes.
Rushmore TH; Kong AN
Curr Drug Metab; 2002 Oct; 3(5):481-90. PubMed ID: 12369894
[TBL] [Abstract][Full Text] [Related]
5. Signal transduction events elicited by natural products: role of MAPK and caspase pathways in homeostatic response and induction of apoptosis.
Kong AN; Yu R; Chen C; Mandlekar S; Primiano T
Arch Pharm Res; 2000 Feb; 23(1):1-16. PubMed ID: 10728649
[TBL] [Abstract][Full Text] [Related]
6. Induction of phase I, II and III drug metabolism/transport by xenobiotics.
Xu C; Li CY; Kong AN
Arch Pharm Res; 2005 Mar; 28(3):249-68. PubMed ID: 15832810
[TBL] [Abstract][Full Text] [Related]
7. Differential activation of MAPK and ICE/Ced-3 protease in chemical-induced apoptosis. The role of oxidative stress in the regulation of mitogen-activated protein kinases (MAPKs) leading to gene expression and survival or activation of caspases leading to apoptosis.
Kong AN; Yu R; Lei W; Mandlekar S; Tan TH; Ucker DS
Restor Neurol Neurosci; 1998 Jun; 12(2-3):63-70. PubMed ID: 12671299
[TBL] [Abstract][Full Text] [Related]
8. Involvement of Nrf2 and JNK1 in the activation of antioxidant responsive element (ARE) by chemopreventive agent phenethyl isothiocyanate (PEITC).
Keum YS; Owuor ED; Kim BR; Hu R; Kong AN
Pharm Res; 2003 Sep; 20(9):1351-6. PubMed ID: 14567627
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol inhibits phorbol ester and UV-induced activator protein 1 activation by interfering with mitogen-activated protein kinase pathways.
Yu R; Hebbar V; Kim DW; Mandlekar S; Pezzuto JM; Kong AN
Mol Pharmacol; 2001 Jul; 60(1):217-24. PubMed ID: 11408617
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics and toxicodynamics of drug action: signaling in cell survival and cell death.
Kong AN; Mandlekar S; Yu R; Lei W; Fasanmande A
Pharm Res; 1999 Jun; 16(6):790-8. PubMed ID: 10397596
[TBL] [Abstract][Full Text] [Related]
11. Dietary chemopreventive compounds and ARE/EpRE signaling.
Chen C; Kong AN
Free Radic Biol Med; 2004 Jun; 36(12):1505-16. PubMed ID: 15182853
[TBL] [Abstract][Full Text] [Related]
12. In vivo pharmacokinetics, activation of MAPK signaling and induction of phase II/III drug metabolizing enzymes/transporters by cancer chemopreventive compound BHA in the mice.
Hu R; Shen G; Yerramilli UR; Lin W; Xu C; Nair S; Kong AN
Arch Pharm Res; 2006 Oct; 29(10):911-20. PubMed ID: 17121188
[TBL] [Abstract][Full Text] [Related]
13. Nrf2: a potential molecular target for cancer chemoprevention by natural compounds.
Jeong WS; Jun M; Kong AN
Antioxid Redox Signal; 2006; 8(1-2):99-106. PubMed ID: 16487042
[TBL] [Abstract][Full Text] [Related]
14. Induction of detoxifying enzymes by garlic organosulfur compounds through transcription factor Nrf2: effect of chemical structure and stress signals.
Chen C; Pung D; Leong V; Hebbar V; Shen G; Nair S; Li W; Kong AN
Free Radic Biol Med; 2004 Nov; 37(10):1578-90. PubMed ID: 15477009
[TBL] [Abstract][Full Text] [Related]
15. Role of a mitogen-activated protein kinase pathway in the induction of phase II detoxifying enzymes by chemicals.
Yu R; Lei W; Mandlekar S; Weber MJ; Der CJ; Wu J; Kong AN
J Biol Chem; 1999 Sep; 274(39):27545-52. PubMed ID: 10488090
[TBL] [Abstract][Full Text] [Related]
16. Chemoprotection by organosulfur inducers of phase 2 enzymes: dithiolethiones and dithiins.
Kensler TW; Curphey TJ; Maxiutenko Y; Roebuck BD
Drug Metabol Drug Interact; 2000; 17(1-4):3-22. PubMed ID: 11201301
[TBL] [Abstract][Full Text] [Related]
17. Anticarcinogenesis by dietary phytochemicals: cytoprotection by Nrf2 in normal cells and cytotoxicity by modulation of transcription factors NF-kappa B and AP-1 in abnormal cancer cells.
Gopalakrishnan A; Tony Kong AN
Food Chem Toxicol; 2008 Apr; 46(4):1257-70. PubMed ID: 17950513
[TBL] [Abstract][Full Text] [Related]
18. Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals.
Surh YJ; Kundu JK; Na HK
Planta Med; 2008 Oct; 74(13):1526-39. PubMed ID: 18937164
[TBL] [Abstract][Full Text] [Related]
19. Butylated hydroxyanisole regulates ARE-mediated gene expression via Nrf2 coupled with ERK and JNK signaling pathway in HepG2 cells.
Yuan X; Xu C; Pan Z; Keum YS; Kim JH; Shen G; Yu S; Oo KT; Ma J; Kong AN
Mol Carcinog; 2006 Nov; 45(11):841-50. PubMed ID: 16739127
[TBL] [Abstract][Full Text] [Related]
20. Cancer chemoprevention by phytochemicals: potential molecular targets, biomarkers and animal models.
Kwon KH; Barve A; Yu S; Huang MT; Kong AN
Acta Pharmacol Sin; 2007 Sep; 28(9):1409-21. PubMed ID: 17723174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
